OSUR

OraSure Technologies, Inc. NASDAQ

Healthcare ·Medical - Instruments & Supplies ·US · orasure.com

$2.95

Mkt Cap $203.9M

52w Low $2.08 50.0% of range 52w High $3.82

50d MA $3.04 200d MA $2.88

P/E (TTM) -3.1x

EV/EBITDA -3.4x

P/B 0.6x

Debt/Equity 0.0x

ROE -20.2%

P/FCF -3341.5x

RSI (14) —

ATR (14) —

Beta 0.85

50d MA $3.04

200d MA $2.88

Avg Volume 473.5K

About

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSw…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 25, 2026	AMC	-0.17	-0.19	-11.8%	2.80	-10.4%	+10.0%	+12.5%	+5.7%	+6.4%	+7.5%	—
Nov 5, 2025	AMC	-0.16	-0.13	+18.8%	2.57	-4.3%	-6.6%	-6.6%	-9.3%	-4.3%	-3.9%	—
Aug 5, 2025	AMC	-0.15	-0.19	-26.7%	3.12	-10.3%	-8.3%	-11.9%	-10.9%	-10.6%	-10.3%	—
May 7, 2025	AMC	-0.15	-0.18	-20.0%	2.79	-3.6%	-6.8%	-10.0%	-4.3%	-5.0%	-10.8%	—
Feb 25, 2025	AMC	-0.05	-0.06	-20.0%	4.00	-17.5%	-23.5%	-21.8%	-13.0%	-10.8%	-15.8%	—
Nov 6, 2024	AMC	-0.01	-0.01	-22.0%	4.40	+4.5%	-3.6%	-2.5%	-3.6%	-5.9%	-8.0%	—
Aug 6, 2024	AMC	0.04	0.07	+66.7%	4.32	+13.7%	+0.5%	+6.2%	-2.3%	-4.9%	-3.7%	—
May 8, 2024	AMC	-0.01	0.04	+766.7%	5.31	-5.8%	-4.9%	-8.5%	-2.8%	+2.6%	+1.5%	—
Feb 27, 2024	AMC	0.09	0.27	+200.0%	7.03	+4.1%	+10.0%	+2.4%	+3.4%	-2.0%	-0.4%	—
Nov 7, 2023	AMC	0.07	0.27	+285.7%	5.75	+1.0%	+2.9%	+8.0%	+12.3%	+13.7%	+18.3%	—
Aug 3, 2023	AMC	-0.06	-0.07	-16.7%	4.49	+7.8%	+32.3%	+42.5%	+44.5%	+39.2%	+40.5%	—
May 10, 2023	AMC	0.14	0.37	+164.3%	7.05	+1.8%	+4.8%	-14.8%	-24.0%	-24.7%	-23.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Nov 12	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$2.46	$2.43	-1.2%	+0.4%	-7.3%	-6.1%	-8.5%	-13.8%
May 19	Evercore ISI	Maintains	In Line → In Line	—	$2.43	$2.42	-0.4%	+8.2%	+15.2%	+4.9%	+5.8%	+3.7%
May 8	Evercore ISI	Maintains	In Line → In Line	—	$2.79	$2.69	-3.6%	-6.8%	-10.0%	-4.3%	-5.0%	-10.8%
Aug 7	Evercore ISI	Maintains	In Line → In Line	—	$4.32	$4.91	+13.7%	+0.5%	+6.2%	-2.3%	-4.9%	-3.7%
Jul 2	Evercore ISI	Maintains	In Line → In Line	—	$4.27	$4.23	-0.9%	-4.4%	-5.6%	-8.0%	-4.2%	-4.0%
May 13	JP Morgan	Maintains	Neutral → Neutral	—	$4.86	$4.83	-0.6%	+6.2%	+12.1%	+10.9%	+7.6%	+1.2%
Apr 4	Evercore ISI	Maintains	In Line → In Line	—	$6.18	$6.20	+0.3%	-2.8%	-3.6%	-4.2%	-4.0%	-6.3%
Feb 29	JP Morgan	Maintains	Neutral → Neutral	—	$7.73	$7.81	+1.0%	-6.9%	-6.0%	-10.9%	-9.4%	-9.8%
Dec 11	Citigroup	Maintains	Buy → Buy	—	$7.10	$7.11	+0.1%	-0.1%	+3.0%	+4.4%	+3.5%	+7.7%
Nov 8	JP Morgan	Maintains	Neutral → Neutral	—	$5.75	$5.81	+1.0%	+2.9%	+8.0%	+12.3%	+13.7%	+18.3%
Jul 17	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$4.68	$4.65	-0.6%	-2.4%	-3.8%	-3.0%	-6.0%	-3.4%
May 11	Citigroup	Maintains	Buy → Buy	—	$5.27	$5.20	-1.3%	-2.5%	-2.1%	+2.8%	-3.0%	-0.8%
Feb 24	Citigroup	Maintains	Buy → Buy	—	$7.51	$7.00	-6.8%	+3.3%	+7.2%	+3.9%	+2.5%	+2.3%
Sep 22	Raymond James	Downgrade	Outperform → Market Perform	—	$13.34	$12.66	-5.1%	-16.1%	-16.2%	-18.2%	-18.0%	-20.5%
Aug 4	Raymond James	Maintains	Outperform → Outperform	—	$12.41	$10.65	-14.1%	-3.5%	-3.5%	-5.2%	-6.6%	-8.8%
Jun 28	Raymond James	Maintains	Outperform → Outperform	—	$9.56	$9.52	-0.4%	+5.9%	+8.4%	+6.1%	+8.5%	+6.8%
May 6	Raymond James	Maintains	Outperform → Outperform	—	$9.02	$9.16	+1.6%	+7.9%	+9.3%	+7.9%	+5.9%	+2.9%
Aug 21	Evercore ISI	Maintains	Outperform → Outperform	—	$13.19	$13.57	+2.9%	+12.1%	+9.3%	+14.4%	+9.2%	-12.6%
Aug 10	Citigroup	Maintains	Buy → Buy	—	$14.05	$14.20	+1.1%	+3.6%	-4.6%	-1.9%	-4.3%	-6.2%
Aug 10	JP Morgan	Maintains	Neutral → Neutral	—	$14.05	$14.20	+1.1%	+3.6%	-4.6%	-1.9%	-4.3%	-6.2%
Aug 7	Raymond James	Upgrade	Market Perform → Outperform	—	$13.09	$13.77	+5.2%	+7.3%	+11.2%	+2.4%	+5.3%	+2.7%
May 9	Canaccord Genuity	Downgrade	Buy → Hold	—	$9.75	$8.64	-11.4%	-8.0%	-6.2%	-12.6%	-10.4%	-9.0%
Jul 16	Stephens & Co.	Downgrade	Overweight → Equal Weight	—	$17.30	$16.15	-6.6%	-5.9%	-3.4%	-3.5%	-2.3%	-2.1%
Nov 2	Jefferies	Downgrade	Buy → Hold	—	$19.02	$14.52	-23.7%	-27.7%	-22.1%	-23.8%	-27.2%	-29.3%
Aug 3	Canaccord Genuity	Maintains	Buy → Buy	—	$17.27	$18.73	+8.5%	+16.7%	+19.3%	+22.8%	+24.3%	+21.3%
Feb 9	Raymond James	Upgrade	Market Perform → Outperform	—	$8.85	$10.06	+13.7%	+18.5%	+18.8%	+18.5%	+22.7%	+25.6%
Dec 21	CL King	Maintains	Buy → Buy	—	$8.88	$9.00	+1.4%	+1.2%	-1.5%	-1.5%	-0.2%	-1.1%
Sep 19	BTIG Research	Downgrade	Buy → Neutral	—	$8.65	$8.36	-3.4%	-2.2%	-3.5%	-1.8%	-1.8%	-3.9%
Sep 19	BTIG	Downgrade	Buy → Neutral	—	$8.65	$8.36	-3.4%	-2.2%	-3.5%	-1.8%	-1.8%	-3.9%
Aug 29	Stephens & Co.	Upgrade	Equal Weight → Overweight	—	$7.85	$8.24	+5.0%	+10.3%	+9.3%	+9.2%	+9.0%	+11.1%
Aug 24	Canaccord Genuity	Maintains	Buy → Buy	—	$7.00	$7.48	+6.9%	+10.6%	+10.9%	+12.1%	+23.7%	+22.6%
Aug 4	Jefferies	Maintains	Buy → Buy	—	$6.81	$6.95	+2.1%	+2.5%	+7.3%	+6.3%	+5.7%	+3.5%
Jun 13	Raymond James	Downgrade	Outperform → Market Perform	—	$7.78	$7.40	-4.9%	-12.2%	-10.2%	-10.0%	-10.7%	-10.8%
Nov 11	Canaccord Genuity	Maintains	Buy → Buy	—	$6.00	$6.04	+0.7%	-3.3%	-5.3%	-2.2%	-2.3%	-0.7%
Jun 17	Jefferies	Maintains	Buy → Buy	—	$5.65	$5.69	+0.7%	+1.8%	+5.3%	+6.4%	+3.2%	+3.2%
May 7	JMP Securities	Downgrade	Market Outperform → Market Perform	—	$6.16	$5.39	-12.5%	-13.5%	-10.7%	-12.2%	-14.3%	-14.6%
May 7	Jefferies	Maintains	Buy → Buy	—	$6.16	$5.39	-12.5%	-13.5%	-10.7%	-12.2%	-14.3%	-14.6%
May 6	Canaccord Genuity	Maintains	Buy → Buy	—	$6.08	$6.03	-0.7%	+1.4%	-12.3%	-9.5%	-10.9%	-13.1%
Dec 31	Jefferies	Maintains	Buy → Buy	—	$10.17	$10.40	+2.3%	-0.3%	-2.2%	-1.0%	-3.8%	+0.5%
Oct 16	Canaccord Genuity	Maintains	Buy → Buy	—	$8.34	$9.35	+12.1%	+3.1%	-0.1%	-2.6%	+1.4%	-0.2%
Jun 12	Canaccord Genuity	Maintains	Buy → Buy	—	$7.48	$7.44	-0.5%	+4.3%	+8.2%	+11.8%	+14.8%	+17.1%
Jun 12	Jefferies	Maintains	Buy → Buy	—	$7.48	$7.44	-0.5%	+4.3%	+8.2%	+11.8%	+14.8%	+17.1%
May 8	Raymond James	Maintains	Outperform → Outperform	—	$6.59	$6.55	-0.6%	-8.5%	-8.6%	-2.9%	-1.8%	-5.9%
Nov 7	Stephens & Co.	Downgrade	Overweight → Equal Weight	—	$5.97	$6.24	+4.5%	+6.9%	+14.9%	+17.4%	+19.3%	+18.6%
Jul 16	Cowen & Co.	Upgrade	Market Perform → Outperform	—	$4.62	$4.85	+5.0%	+6.7%	+7.4%	+11.9%	+11.5%	+8.2%
May 31	Jefferies	Maintains	Buy → Buy	—	$4.47	$4.58	+2.5%	-2.0%	-1.6%	-3.1%	-3.4%	-3.8%
Mar 28	Stephens & Co.	Maintains	Overweight → Overweight	—	$5.32	$5.38	+1.1%	+1.5%	-0.6%	-1.7%	-3.9%	-4.7%
Feb 7	Jefferies	Maintains	Buy → Buy	—	$7.02	$6.80	-3.1%	-13.1%	-13.4%	-16.7%	-16.7%	-17.1%
Nov 8	Jefferies	Maintains	Buy → Buy	—	$8.66	$8.02	-7.4%	-12.1%	-15.4%	-13.2%	-13.7%	-14.8%
Oct 15	Raymond James	Maintains	Market Perform → Perform	—	$9.85	$9.88	+0.3%	+0.0%	-1.6%	-2.6%	-3.6%	-5.6%

Recent Filings

8-K · 1.01 !! High

OraSure Technologies Inc -- 8-K 1.01: Material Agreement

OraSure Technologies entered into an agreement with Altai Capital Management, potentially providing capital access or strategic partnership that could support operational funding or growth initiatives for the diagnostic testing company.

Apr 17

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

OraSure's stabilizing public health funding and near-term catalysts position it for revenue growth and margin expansion, making OSUR attractive for investors seeking profitability turnaround potential.

Mar 30

8-K · 5.02 !!! Very High

OraSure Technologies Inc -- 8-K 5.02: Executive Change

David Shulkin's resignation from OraSure Technologies' board effective March 2, 2026, removes an experienced director but signals no immediate operational concerns for the company.

Mar 5

8-K · 7.01 ! Medium

OraSure Technologies Inc -- 8-K 7.01: Regulation FD Disclosure

OraSure Technologies held a February 2026 analyst webcast where management discussed full-year 2025 financial results and business developments, providing investors with updated performance guidance and strategic direction.

Feb 25

Data updated apr 26, 2026 6:04pm · Source: massive.com